NCT06894940View on ClinicalTrials.gov

Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies

PHASE2CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
Multiple Sclerosis
Interventions
BEHAVIORAL

Active Comparator #1

task oriented rehabilitation

BEHAVIORAL

Placebo

passive rehabilitation

BEHAVIORAL

Experimental

rehabilitation with virtual reality

Trial Locations (1)

27100

ICS Salvatore Maugeri, Pavia, Pavia

All Listed Sponsors
collaborator

University of Genova

OTHER

collaborator

Consorzio per Valutazioni Biologiche e Farmacologiche

OTHER

collaborator

A.O.U. Città della Salute e della Scienza

OTHER

lead

University of Pavia

OTHER